
Covering a very interesting study this week, which investiaged the PDE4B inhibitor nerandomilast for patients with progressive pulmonary fibrosis (specifically including 325 patients with autoimmune ILD). Would have been yet another ho hum trial if not for the big reveal... have a listen to find out! Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2503643
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

E135: IL17 and a GLP1?

E134: Brepocitinib in Dermatomyositis (VALOR)

E133: Obinutuzumab for SLE (ALLEGORY)

E132: Romosozumab vs teriparatide for osteoproosis (STRUCTURE)
Free AI-powered recaps of The Evidence Based Rheumatology Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.